Cosmos Health Inc. (COSM)
(Real Time Quote from BATS)
$0.81 USD
-0.01 (-0.72%)
Updated Oct 18, 2024 12:30 PM ET
4-Sell of 5 4
D Value B Growth D Momentum D VGM
Balance Sheet
Fiscal Year End for Cosmos Health Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 4 | 21 | 0 | 1 | 0 |
Receivables | 21 | 26 | 30 | 27 | 9 |
Notes Receivable | 1 | 1 | 0 | 0 | 0 |
Inventories | 5 | 3 | 3 | 3 | 3 |
Other Current Assets | 6 | 5 | 6 | 9 | 7 |
Total Current Assets | 37 | 56 | 41 | 41 | 21 |
Net Property & Equipment | 12 | 2 | 2 | 2 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 7 | 8 | 4 | 0 | 0 |
Deferred Charges | 0 | 0 | 1 | 0 | 0 |
Intangibles | 8 | 1 | 0 | 0 | 0 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 66 | 68 | 49 | 44 | 24 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 2 | 2 | 6 | 14 | 15 |
Accounts Payable | 12 | 12 | 13 | 12 | 9 |
Current Portion Long-Term Debt | 7 | 6 | 7 | 7 | 4 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 1 | 1 | 0 |
Income Taxes Payable | 0 | 0 | 1 | 1 | 0 |
Other Current Liabilities | 3 | 1 | 1 | 1 | 0 |
Total Current Liabilities | 24 | 22 | 30 | 35 | 28 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 3 | 4 | 14 | 12 | 2 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 2 | 1 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 30 | 29 | 45 | 48 | 30 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 129 | 112 | 40 | 14 | 14 |
Retained Earnings | -92 | -66 | -34 | -19 | -20 |
Other Equity | 0 | -6 | 0 | 1 | 0 |
Treasury Stock | 1 | 1 | 1 | 1 | 0 |
Total Shareholder's Equity | 36 | 39 | 4 | -4 | -6 |
Total Liabilities & Shareholder's Equity | 66 | 68 | 49 | 44 | 24 |
Total Common Equity | 36 | 39 | 4 | -4 | -6 |
Shares Outstanding | 16.90 | 10.50 | 0.70 | NA | NA |
Book Value Per Share | 2.13 | 3.74 | 6.26 | 0.00 | 0.00 |
Fiscal Year End for Cosmos Health Inc falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 0 | 1 | 4 | 2 |
Receivables | NA | 20 | 20 | 21 | 29 |
Notes Receivable | NA | 1 | 1 | 1 | 1 |
Inventories | NA | 4 | 5 | 5 | 6 |
Other Current Assets | NA | 8 | 7 | 6 | 9 |
Total Current Assets | NA | 33 | 34 | 37 | 46 |
Net Property & Equipment | NA | 12 | 12 | 12 | 12 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 6 | 7 | 7 | 7 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 8 | 8 | 8 | 4 |
Deposits & Other Assets | NA | 0 | 0 | 1 | 1 |
Total Assets | NA | 61 | 62 | 66 | 72 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 2 | 1 | 2 | 1 |
Accounts Payable | NA | 12 | 12 | 12 | 13 |
Current Portion Long-Term Debt | NA | 7 | 6 | 7 | 5 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 4 | 4 | 3 | 3 |
Total Current Liabilities | NA | 25 | 24 | 24 | 23 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 2 | 3 | 3 | 3 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 2 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 29 | 28 | 30 | 27 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 130 | 130 | 129 | 118 |
Retained Earnings | NA | -96 | -94 | -92 | -71 |
Other Equity | NA | -1 | -1 | 0 | -2 |
Treasury Stock | NA | 1 | 1 | 1 | 1 |
Total Shareholder's Equity | NA | 32 | 35 | 36 | 44 |
Total Liabilities & Shareholder's Equity | NA | 61 | 62 | 66 | 72 |
Total Common Equity | 0 | 32 | 35 | 36 | 44 |
Shares Outstanding | 21.00 | 16.90 | 16.90 | 16.90 | 13.00 |
Book Value Per Share | 0.00 | 1.90 | 2.04 | 2.13 | 3.40 |